source
- UK price watchdog recommends against Amgen's Lumakras in lung cancerThe UK’s drug pricing watchdog said government reimbursement of Amgen’s lung cancer drug Lumakras should be cut off for new patients. In draft guidance released on Thursday, the National Institute…Endpoints · 21d ago↗ source
- FDA criticizes Lundbeck for webpages on migraine treatment VyeptiThe FDA has chastised Lundbeck Seattle Biopharmaceuticals for two promotional webpages that made allegedly inflated claims regarding the efficacy of its migraine drug. In an untitled letter sent la…Endpoints · 21d ago↗ source
- GSK ends brain drug alliance with AlectorClinical setbacks derailed what was once a potentially $2.2 billion deal that marked GSK's return to neuroscience.BioPharma Dive